Get my own profile
Public access
View all13 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Thierry LaveVerified email at roche.com
- Tycho HeimbachVerified email at umich.edu
- Filippos KesisoglouDistinguished Scientist, Pharmaceutical Sciences, Merck & Co., Inc.Verified email at merck.com
- Christos ReppasProfessor of Pharmaceutics, National and Kapodistrian University of AthensVerified email at pharm.uoa.gr
- Maria VertzoniNational and Kapodistrian University of Athens, Department of Pharmacy, Associate ProfessorVerified email at pharm.uoa.gr
- Andrés Olivares-MoralesClinical Pharmacologist at Roche pREDVerified email at roche.com
- Stephen HallEli Lilly and CompanyVerified email at lilly.com
- Sheila Annie PetersExecutive Director, Boehringer IngelheimVerified email at boehringer-ingelheim.com
- Michael GertzRoche Pharma Research and Early Development (pRED)Verified email at roche.com
- Stephan SchmidtAssociate Professor of Pharmacy, University of FloridaVerified email at cop.ufl.edu
- Kenichi UmeharaRoche Pharmaceutical Research and Early DevelopmentVerified email at roche.com
- Jennifer DressmanGoethe UniversityVerified email at em.uni-frankfurt.de
- Eric PrinssenExpert Clinical Scientist @ RocheVerified email at roche.com
- Martin KuentzUniversity of Applied Sciences and Arts Northwestern SwitzerlandVerified email at fhnw.ch
- Antonello CarusopRED, F. Hoffmann-La RocheVerified email at roche.com